Delay on Rule That Would Eliminate Medicare Part D Drug Rebates
On January 29, 2021, the Biden Administration delayed implementation of a recently adopted rule that would largely eliminate drug rebates in Medicare Part D. This rule had not yet been implemented and was scheduled to go into effect in 2022. This delay is part of the Biden Administration’s broader freeze on all regulations recently adopted […]
Vertex Has a New Horizon: Curing Type 1 Diabetes
Vertex Pharmaceuticals will launch a clinical trial of VX-880, a stem cell-derived beta cell therapy in type 1 diabetes (T1D).
Timothy Doyle Joins Breakthrough T1D as President and Chief Operating Officer
Doyle will lead organizational operations to broaden Breakthrough T1D’s reach and impact.
Department of Health & Human Services Freezes Rule Related to Insulin
As you may have heard from reports in the media the Biden Administration froze a recent regulation on insulin. Want to know what the headlines mean? Read on to get all the details. On January 21, the Biden Administration placed a freeze on all newly published regulations set forth by the previous Administration that had not yet been implemented. This includes a regulation that will require community health […]
Why Does One Scientist Seek to Find Cures for T1D? Answer: His Children
Douglas Melton, Ph.D., can now produce unlimited quantities of beta cells. He now wants to evade the immune attack. See our video to find out more.
COVID-19 Vaccine Access Guide
Breakthrough T1D has been closely monitoring the data on how COVID-19 affects people with T1D and new information about the COVID-19 vaccines.
It’s Official: Teplizumab is Under Review by the FDA
The FDA regulatory review is now under way for teplizumab, to prevent or delay T1D in at-risk individuals. The target action date is July 2, 2021.
What We Can Be Proud Of in 2020
It’s been a tough year, to say the least. But there’s news that we can be proud of in type 1 diabetes research and advocacy. Really proud of.
Breakthrough T1D Video: “Wouldn’t Have Happened Without Breakthrough T1D”
Dr. Robert Langer co-founded Moderna, who gained emergency use approval for its COVID vaccine. Watch the video to find out how Breakthrough T1D is helping to advance his research.
Discovery to Translation: Clinical Trial of a JAK Inhibitor in T1D
A Breakthrough T1D-funded clinical trial will test if a JAK inhibitor will preserve beta cell function in children and young adults with recently diagnosed T1D.
